KANE BIOTECH INC (KNBIF:OTCMKTS)
$0.0185 -0.0034 (-15.5251%)
Analysed KANE BIOTECH INC (KNBIF:OTCMKTS) News Sources
Kane Biotech Restarts Commercial Activities and Strengthens North American Management
12-02-2026
yahoo.com
Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress
13-05-2026
yahoo.com
Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference
16-04-2026
yahoo.com
Kane Biotech Announces the Oversubscription and Closing of Private Placement Offering
26-05-2026
yahoo.com
Kane Biotech Announces First Quarter 2026 Financial Results
28-05-2026
yahoo.com
Kane Biotech Announces Grant of Stock Options
29-05-2026
yahoo.com
Kane Biotech Announces Results of Annual and Special Meeting of Shareholders
02-07-2026
yahoo.com
Kane Biotech Announces Engagement of DNA Advisors
05-08-2026
yahoo.com
Kane Biotech’s revyve® Research Presented at Military Health System Research Symposium
25-08-2026
yahoo.com
Kane Biotech Announces Second Quarter 2026 Financial Results
27-08-2026
yahoo.com
What is the current price of KANE BIOTECH INC (KNBIF:OTCMKTS)?
The current price of KANE BIOTECH INC (KNBIF:OTCMKTS) is $0.0185.
KANE BIOTECH INC (KNBIF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of KANE BIOTECH INC (KNBIF:OTCMKTS) since the previous trading day is $-0.0034.
KANE BIOTECH INC (KNBIF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of KANE BIOTECH INC (KNBIF:OTCMKTS) since the previous trading day is -15.5251%.
What is the most recent average sentiment score for KANE BIOTECH INC (KNBIF:OTCMKTS)?
The most recent average sentiment score for KANE BIOTECH INC (KNBIF:OTCMKTS) is 65 out of 100.
What is the most recent average sentiment for KANE BIOTECH INC (KNBIF:OTCMKTS)?
The most recent sentiment for KANE BIOTECH INC (KNBIF:OTCMKTS) is .
SEC-8K** Filing Available For KANE BIOTECH INC (KNBIF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.